Chronic Pelvic Pain and Adhesions

Michael P. Diamond, Manvinder Singh, Elizabeth E. Puscheck
In: Chronic Pelvic Pain · 2011 · pp. 71–76 · doi:10.1002/9781444391855.ch7 · W1522805019
other OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This paper reviews the role of postoperative adhesions in chronic pelvic pain, notes the challenges and limited success of adhesiolysis, and suggests antiadhesion adjuvants may improve outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Postoperative adhesions develop in the overwhelming majority of women after both open and laparoscopic surgical procedures. Such adhesions may be a major contributing factor to chronic pelvic pain but often coexist with other pathologic processes such as endometriosis. Studies examining the value of adhesiolysis for reduction of pelvic pain have failed to demonstrate major benefit, but likely are constrained by the high incidence of adhesion reformation and the difficulty in successfully reducing the development of postoperative adhesions. The use of antiadhesion adjuvants in combination with adhesiolysis may offer benefit in future studies, particularly as the efficacy of surgical approaches, equipment, and adjuvants in reducing postoperative adhesions is enhanced.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK